Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Feb-22 5:54 PM View:  | Arcellx, Inc. (ACLX) | 08-Feb-22 | Conversion | 2,095,110 | -- | -- | 100% 0 to 2.1M | |
| 04-Sep-19 1:20 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-19 | Payment of Exercise | 7,024 | $5.43 | $38,140.30 | (2%) 462.36K to 455.34K | (598%) |
| 27-Feb-19 7:49 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 26-Feb-19 | Payment of Exercise | 926 | $11.95 | $11,065.70 | (< 1%) 462.29K to 461.36K | (217%) |
| 07-Feb-19 5:18 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Feb-19 | Payment of Exercise | 3,144 | $11.43 | $35,935.90 | (< 1%) 465.43K to 462.29K | (231%) |
| 13-Nov-18 8:32 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Nov-18 | Option Exercise | 91,217 | $4.56 | $415,950.00 | 24% 374.21K to 465.43K | |
| 05-Sep-18 1:00 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-18 | Payment of Exercise | 7,024 | $14.00 | $98,336.00 | (2%) 381.24K to 374.21K | (171%) |
| 28-Feb-18 7:26 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 26-Feb-18 | Grant | 5,000 | -- | -- | 1% 376.24K to 381.24K | |
| 07-Feb-18 2:19 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Feb-18 | Payment of Exercise | 3,137 | $18.42 | $57,783.50 | (< 1%) 379.37K to 376.24K | (106%) |
| 06-Sep-17 8:00 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-17 | Payment of Exercise | 7,827 | $34.34 | $268,779.00 | (2%) 389.79K to 381.96K | (10%) |
| 03-Mar-17 1:38 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Mar-17 | Payment of Exercise | 34,532 | $44.77 | $1,546,000.00 | (8%) 423.29K to 388.75K | 15% |
| 09-Feb-17 7:36 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 07-Feb-17 | Grant | 16,875 | -- | -- | 4% 406.41K to 423.29K | |
| 05-Jan-17 2:32 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 03-Jan-17 | Payment of Exercise | 5,065 | $48.60 | $246,159.00 | (1%) 433.89K to 428.83K | 22% |
| 23-Dec-16 5:11 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 23-Dec-16 | Option Exercise | 30,000 | $5.54 | $166,103.00 | 7% 433.89K to 463.89K | |
| 23-Dec-16 5:11 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 23-Dec-16 | Market Option Sale (Planned) | 30,000 | $50.50 | $1,514,860.00 | (6%) 463.89K to 433.89K | 25% |
| 15-Sep-16 7:09 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 14-Sep-16 | Gift | 407 | -- | -- | (< 1%) 434.3K to 433.89K | |
| 01-Sep-16 7:30 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-16 | Payment of Exercise | 7,613 | $44.74 | $340,606.00 | (2%) 464.33K to 456.71K | 15% |
| 01-Sep-16 7:30 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-16 | Gift | 22,416 | $44.74 | $1,002,890.00 | (5%) 456.71K to 434.3K | 15% |
| 09-Feb-17 7:36 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-16 | Gift | 22,416 | -- | -- | (5%) 428.83K to 406.41K | |
| 29-Aug-16 6:41 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 25-Aug-16 | Grant | 42,500 | -- | -- | 10% 421.83K to 464.33K | |
| 13-May-16 6:10 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 06-May-16 | Option Exercise | 81,300 | $1.23 | $99,999.00 | 24% 340.53K to 421.83K | |
| 22-Apr-16 5:52 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 21-Apr-16 | Option Exercise | 48,121 | $8.49 | $408,547.00 | 14% 340.53K to 388.65K | |
| 22-Apr-16 5:52 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 21-Apr-16 | Market Option Sale (Planned) | 48,121 | $48.05 | $2,312,210.00 | (12%) 388.65K to 340.53K | 21% |
| 22-Apr-16 5:52 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 20-Apr-16 | Option Exercise | 550 | $8.49 | $4,669.50 | < 1% 340.53K to 341.08K | |
| 22-Apr-16 5:52 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 20-Apr-16 | Market Option Sale (Planned) | 550 | $48.00 | $26,400.00 | (< 1%) 341.08K to 340.53K | 21% |
| 18-Apr-16 5:28 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 15-Apr-16 | Option Exercise | 1,405 | $8.49 | $11,928.40 | < 1% 340.53K to 341.93K | |
| 18-Apr-16 5:28 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 15-Apr-16 | Market Option Sale (Planned) | 1,405 | $48.00 | $67,440.00 | (< 1%) 341.93K to 340.53K | 21% |
| 15-Apr-16 2:29 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 14-Apr-16 | Option Exercise | 2,725 | $8.49 | $23,135.20 | < 1% 340.53K to 343.25K | |
| 15-Apr-16 2:29 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 14-Apr-16 | Market Option Sale (Planned) | 2,725 | $48.00 | $130,800.00 | (< 1%) 343.25K to 340.53K | 21% |
| 07-Apr-16 11:59 AM View: | Five Prime Therapeutics, Inc. (FPRX) | 06-Apr-16 | Option Exercise | 26,852 | $8.49 | $227,973.00 | 8% 340.53K to 367.38K | |
| 07-Apr-16 11:59 AM View: | Five Prime Therapeutics, Inc. (FPRX) | 06-Apr-16 | Market Option Sale (Planned) | 26,852 | $43.17 | $1,159,200.00 | (7%) 367.38K to 340.53K | 12% |
| 07-Apr-16 11:59 AM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Apr-16 | Option Exercise | 25,949 | $8.49 | $220,307.00 | 8% 340.53K to 366.48K | |
| 07-Apr-16 11:59 AM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Apr-16 | Market Option Sale (Planned) | 25,949 | $43.00 | $1,115,810.00 | (7%) 366.48K to 340.53K | 12% |
| 31-Mar-16 6:42 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 30-Mar-16 | Option Exercise | 14,044 | $6.89 | $96,763.20 | 4% 340.53K to 354.57K | |
| 31-Mar-16 6:42 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 30-Mar-16 | Market Option Sale (Planned) | 14,044 | $40.02 | $562,041.00 | (4%) 354.57K to 340.53K | 5% |
| 31-Mar-16 6:42 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 29-Mar-16 | Option Exercise | 9,215 | $6.89 | $63,491.30 | 3% 340.53K to 349.74K | |
| 31-Mar-16 6:42 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 29-Mar-16 | Market Option Sale (Planned) | 9,215 | $40.01 | $368,692.00 | (3%) 349.74K to 340.53K | 5% |
| 03-Mar-16 7:18 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 02-Mar-16 | Option Exercise | 23,259 | $6.89 | $160,254.00 | 7% 340.35K to 363.61K | |
| 03-Mar-16 7:18 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 02-Mar-16 | Market Option Sale (Planned) | 23,259 | $36.01 | $837,557.00 | (6%) 363.61K to 340.35K | (5%) |
| 08-Feb-16 5:00 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 04-Feb-16 | Option Exercise | 71,229 | $4.56 | $324,804.00 | 21% 340.35K to 411.58K | |
| 08-Feb-16 5:00 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 04-Feb-16 | Market Option Sale (Planned) | 71,229 | $33.35 | $2,375,600.00 | (17%) 411.58K to 340.35K | (14%) |
| 28-Dec-15 5:04 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 24-Dec-15 | Gift | 953 | -- | -- | (< 1%) 681.61K to 680.65K | |
| 18-Nov-15 5:03 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 16-Nov-15 | Grant | 50,000 | -- | -- | 17% 291.26K to 341.26K | |
| 26-Oct-15 5:31 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 22-Oct-15 | Gift | 3,337 | -- | -- | (1%) 294.59K to 291.26K | |
| 19-Oct-15 4:41 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 15-Oct-15 | Market Sale (Planned) | 72,352 | $27.24 | $1,970,510.00 | (20%) 366.94K to 294.59K | (39%) |
| 23-Sep-15 5:14 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 21-Sep-15 | Market Sale (Planned) | 2,648 | $22.06 | $58,422.30 | (< 1%) 369.59K to 366.94K | (72%) |
| 21-Aug-15 7:28 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 20-Aug-15 | Grant | 75,000 | -- | -- | 25% 294.59K to 369.59K | |
| 24-Jun-15 5:18 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 22-Jun-15 | Market Sale (Planned) | 75,000 | $24.67 | $1,850,380.00 | (20%) 369.59K to 294.59K | (53%) |
| 04-May-15 4:41 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 30-Apr-15 | Grant | 13,090 | -- | -- | 4% 356.5K to 369.59K | |
| 04-Nov-14 5:35 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 04-Nov-14 | Market Sale (Planned) | 7,143 | $13.11 | $93,649.70 | (2%) 363.65K to 356.5K | (189%) |
| 04-Nov-14 5:35 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 03-Nov-14 | Market Sale (Planned) | 13,559 | $13.05 | $177,007.00 | (4%) 377.2K to 363.65K | (190%) |